Envoy Medical, Inc. - 10-Q Filing

Envoy Medical, Inc. reports Q3 financial results for the period ending September 30, 2026, featuring complex equity instruments and multiple term loan structures.

SEC EDGAR ·

Tickers: $COCH

Read the full article at SEC EDGAR

More Regulatory news